Literature DB >> 31049368

The interplay among psychological distress, the immune system, and brain tumor patient outcomes.

Sebastian Otto-Meyer1, Jan Lumibao1, Eugene Kim1, Erik Ladomersky1, Lijie Zhai1, Kristen L Lauing1, Denise M Scholtens2, Frank Penedo3, Christina Amidei1, Rimas V Lukas4,5, Derek A Wainwright1.   

Abstract

A malignant brain tumor diagnosis is often accompanied with intense feelings and can be associated with psychosocial conditions including depression, anxiety, and/or increased distress levels. Previous work has highlighted the impact of uncontrolled psychological distress among brain tumor patients. Given the negative impact of maladaptive psychosocial and biobehavioral factors on normal immune system functions, the question remains as to how psychological conditions potentially affect the brain tumor patient anti-tumor immune response. Since immunotherapy has yet to show efficacy at increasing malignant glioma patient survival in all randomized, phase III clinical trials to-date, this review provides new insights into the potential negative effects of chronic distress on brain tumor patient immune functions and outcomes.

Entities:  

Keywords:  Psychosocial; biobehavioral; glioblastoma; glioma; immunosuppression

Year:  2019        PMID： 31049368      PMCID： PMC6487487          DOI： 10.1016/j.cobeha.2019.01.009

Source DB:  PubMed          Journal:  Curr Opin Behav Sci        ISSN： 2352-1546


  89 in total

1.  Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Authors:  John H Sampson; Amy B Heimberger; Gary E Archer; Kenneth D Aldape; Allan H Friedman; Henry S Friedman; Mark R Gilbert; James E Herndon; Roger E McLendon; Duane A Mitchell; David A Reardon; Raymond Sawaya; Robert J Schmittling; Weiming Shi; James J Vredenburgh; Darell D Bigner
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

Review 2.  Psychosocial and supportive-care needs in high-grade glioma.

Authors:  Susan Catt; Anthony Chalmers; Lesley Fallowfield
Journal:  Lancet Oncol       Date:  2008-09       Impact factor: 41.316

3.  Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Authors:  Amy S Darefsky; Joseph T King; Robert Dubrow
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

4.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.

Authors:  Alex J Mitchell; Melissa Chan; Henna Bhatti; Marie Halton; Luigi Grassi; Christoffer Johansen; Nicholas Meader
Journal:  Lancet Oncol       Date:  2011-01-19       Impact factor: 41.316

5.  Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience.

Authors:  Jonathan S Caudill; Paul D Brown; Jane H Cerhan; Teresa A Rummans
Journal:  Am J Clin Oncol       Date:  2011-08       Impact factor: 2.339

6.  Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.

Authors:  Emily Ruden; David A Reardon; April D Coan; James E Herndon; Whitney E Hornsby; Miranda West; Diane R Fels; Annick Desjardins; James J Vredenburgh; Emily Waner; Allan H Friedman; Henry S Friedman; Katherine B Peters; Lee W Jones
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

Review 7.  Depression in cerebral glioma patients: a systematic review of observational studies.

Authors:  Alasdair G Rooney; Alan Carson; Robin Grant
Journal:  J Natl Cancer Inst       Date:  2010-11-24       Impact factor: 13.506

8.  Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.

Authors:  Jennifer Lohr; Thomas Ratliff; Andrea Huppertz; Yingzi Ge; Christine Dictus; Rezvan Ahmadi; Stefan Grau; Nobuyoshi Hiraoka; Volker Eckstein; Rupert C Ecker; Thomas Korff; Andreas von Deimling; Andreas Unterberg; Philipp Beckhove; Christel Herold-Mende
Journal:  Clin Cancer Res       Date:  2011-04-08       Impact factor: 12.531

9.  Association of preoperative depression and survival after resection of malignant brain astrocytoma.

Authors:  Muraya Gathinji; Matthew J McGirt; Frank J Attenello; Kaisorn L Chaichana; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alfredo Quinones-Hinojosa
Journal:  Surg Neurol       Date:  2008-09-11

Review 10.  Quality of life in adults with brain tumors: current knowledge and future directions.

Authors:  Raymond Liu; Margaretta Page; Karla Solheim; Sherry Fox; Susan M Chang
Journal:  Neuro Oncol       Date:  2008-11-10       Impact factor: 12.300
View more
  9 in total

Review 1.  Use of virtual reality for symptom management in solid-tumor patients with implications for primary brain tumor research: a systematic review.

Authors:  Nicole M Leggiero; Terri S Armstrong; Mark R Gilbert; Amanda L King
Journal:  Neurooncol Pract       Date:  2020-03-28

2.  Long-term Survival in a Patient with Butterfly Glioblastoma: A Case Report.

Authors:  Megan Finneran; Dario A Marotta; Dana Altenburger; Emilio Nardone
Journal:  Cureus       Date:  2020-02-07

Review 3.  Immunotherapy Against Gliomas: is the Breakthrough Near?

Authors:  Rimas V Lukas; Derek A Wainwright; Craig M Horbinski; Fabio M Iwamoto; Adam M Sonabend
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

Review 4.  Tryptophan metabolism in brain tumors - IDO and beyond.

Authors:  Michael Platten; Mirco Friedrich; Derek A Wainwright; Verena Panitz; Christiane A Opitz
Journal:  Curr Opin Immunol       Date:  2021-04-01       Impact factor: 7.486

Review 5.  Serotonin Pathway in Cancer.

Authors:  Pragathi Balakrishna; Sagila George; Hassan Hatoum; Sarbajit Mukherjee
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

Review 6.  A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.

Authors:  Erik E Rabin; Miri Kim; Andreas Mozny; Krislyn Cardoza; April C Bell; Lijie Zhai; Prashant Bommi; Kristen L Lauing; Amanda L King; Terri S Armstrong; Theresa L Walunas; Deyu Fang; Ishan Roy; John D Peipert; Erica Sieg; Xinlei Mi; Christina Amidei; Rimas V Lukas; Derek A Wainwright
Journal:  Brain Behav Immun Health       Date:  2022-03-23

Review 7.  Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.

Authors:  Mojgan Barati; Maryam Akhondi; Narges Sabahi Mousavi; Newsha Haghparast; Asma Ghodsi; Hossein Baharvand; Marzieh Ebrahimi; Seyedeh-Nafiseh Hassani
Journal:  Stem Cell Rev Rep       Date:  2021-06-11       Impact factor: 5.739

8.  A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors.

Authors:  Sebastian Otto-Meyer; Rian DeFaccio; Corey Dussold; Erik Ladomersky; Lijie Zhai; Kristen L Lauing; Lakshmi R Bollu; Christina Amidei; Rimas V Lukas; Denise M Scholtens; Derek A Wainwright
Journal:  Brain Behav Immun Health       Date:  2019-12-16

9.  Impact of Anticipated Awake Surgery on Psychooncological Distress in Brain Tumor Patients.

Authors:  Franziska Staub-Bartelt; Oliver Radtke; Daniel Hänggi; Michael Sabel; Marion Rapp
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.